, (NASDAQ: BIOC), a global provider of clinical trial  management services, announced a strategic partnership with 

, Inc., an oncologyfocused  contract research organization (“CRO”). 

“Our partnership will enable customers to benefit from Kaizen’s expertise in worldwide oncology trials and  BioClinica’s best-in-class product suite offering,” said Peter Benton, President of the eClinical Division of  BioClinica. “Kaizen’s oncology focus makes it a strong addition to the BioClinica Certified Partner Program,  supporting customers in the complex therapeutic areas of study monitoring and management.”

 The BioClinica Certified Partner (“BCP”) Program helps CROs address many of the complexities associated  with clinical trials by leveraging the focus and the power of BioClinica software and services. BioClinica  solutions enable CROs to start clinical studies more efficiently, optimize data collection, to ensure timely grants  payments and track performance. BioClinica solutions provide CROs with the optimal means to more  efficiently manage multiple studies with multiple sponsors and to supplement their therapeutic and clinical  expertise with BioClinica’s global clinical technology support.

 Kaizen Clinical Services, based in Jackson, New Jersey, is a woman-owned contract research organization  that focuses on oncology trials. Founded in 2007, Kaizen offers project management, clinical monitoring,  consulting and training services. The firm has managed and/or monitored Phase I through Phase IV trials that  have enrolled between 35 and 2,500 patients. 